Bayer separates business

15 November 2003

Following reorganisation, the Bayer Group announced on November 7 that it intends to maintain its focus on its core businesses and in the future concentrate on health care, nutrition and innovative materials. For this reason, Bayer Chemicals (excluding H C Starck and Wolff Walsrode) is to be combined with certain parts of the polymers business in a new company with the provisional name 'NewCo'. Effectively the company is spinning-off its chemicals and polymers businesses which includes leather chemicals. The aim is for this company to be listed on the stock market under a new name by early 2005 at the latest. The Supervisory Board approved these plans of the group management board. CEO designate of the new company is Dr Axel Claus Heitmann (44), currently a member of the executive committee of Bayer Polymers and head of that company's Asia region, headquartered in Shanghai.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.